Literature DB >> 1340863

Persistent pulmonary arterial hypertension of the newborn.

A Narang1, O N Bhakoo, P M Nair, V Bhandari.   

Abstract

Persistent pulmonary hypertension of the newborn (PPHN) characterised by right to left shunting with intense cyanosis is difficult to manage, and in the best of centres carries a 40-60 percent mortality. We report our one year's experience of managing six neonates with PPHN. There were 5 males and 1 female with mean birth weight of 2.59 +/- 0.487 kg and gestation period 39 +/- 2.0 wks and 1 minute Apgar score 2.8 +/- 2.1. Four to six babies were born by cesarean section and 3-6 babies had aspiration pneumonia. All babies presented within 12 hours of age (mean 5.08 +/- 5 hrs) with intense cyanosis and respiratory distress. Diagnosis were confirmed in all by (a) hyperoxia test, (b) simultaneous determination of preductal and postductal paO2 (c) contrast echocardiography and (d) hyperoxia-hyperventilation test. Babies were managed with hyperventilation using mean ventilatory rates of 100 +/- 45 per minute, an inspired oxygen concentration of 100%, peak inspiratory pressures 27 +/- 9 cm of H2O, and expiratory pressures 5 +/- 1.6 cms of H2O, and mean air way pressures of 10.4 +/- 2.7 cms H2O. Alkali therapy was used in 3 of the six babies whereas low dose dopamine was infused in all six babies. Inspite of aggressive ventilatory therapy, only 3 out of 6 babies could be salvaged.

Entities:  

Mesh:

Year:  1992        PMID: 1340863     DOI: 10.1007/bf02859410

Source DB:  PubMed          Journal:  Indian J Pediatr        ISSN: 0019-5456            Impact factor:   1.967


  18 in total

1.  Persistence of the fetal circulation: a commentary.

Authors:  W M Gersony
Journal:  J Pediatr       Date:  1973-06       Impact factor: 4.406

2.  The clinical profile of the newborn with persistent pulmonary hypertension. Observations in 19 affected neonates.

Authors:  W H Drummond; G J Peckham; W W Fox
Journal:  Clin Pediatr (Phila)       Date:  1977-04       Impact factor: 1.168

Review 3.  The structural basis of PPHN.

Authors:  R L Geggel; L M Reid
Journal:  Clin Perinatol       Date:  1984-10       Impact factor: 3.430

Review 4.  Persistent pulmonary hypertension in the neonate: diagnosis and management.

Authors:  W W Fox; S Duara
Journal:  J Pediatr       Date:  1983-10       Impact factor: 4.406

5.  Noninvasive assessment of cardiac function and pulmonary hypertension in persistent pulmonary hypertension of the newborn.

Authors:  G W Henry
Journal:  Clin Perinatol       Date:  1984-10       Impact factor: 3.430

6.  Use of cardiotonic therapy in the management of infants with PPHN.

Authors:  W H Drummond
Journal:  Clin Perinatol       Date:  1984-10       Impact factor: 3.430

Review 7.  Neonatal 'pulmonary vasodilator' drugs. Current status.

Authors:  W H Drummond; J E Lock
Journal:  Dev Pharmacol Ther       Date:  1984

8.  Refractory hypoxemia associated with neonatal pulmonary disease: the use and limitations of tolazoline.

Authors:  D K Stevenson; D S Kasting; R A Darnall; R L Ariagno; J D Johnson; N Malachowski; C L Beets; P Sunshine
Journal:  J Pediatr       Date:  1979-10       Impact factor: 4.406

9.  Tolazoline therapy for persistent pulmonary hypertension after congenital diaphragmatic hernia repair.

Authors:  R S Bloss; T Turmen; H E Beardmore; J V Aranda
Journal:  J Pediatr       Date:  1980-12       Impact factor: 4.406

10.  Pulmonary hypertension in the perinatal aspiration syndromes.

Authors:  W W Fox; M H Gewitz; R Dinwiddie; W H Drummond; G J Peckham
Journal:  Pediatrics       Date:  1977-02       Impact factor: 7.124

View more
  2 in total

1.  Neonatal mechanical ventilation--experience at a level II care centre.

Authors:  S Nangia; A Saili; A K Dutta; V Gaur; M Singh; A Seth; S Kumari
Journal:  Indian J Pediatr       Date:  1998 Mar-Apr       Impact factor: 1.967

2.  Assisted ventilation in neonates: the Manipal experience.

Authors:  L Krishnan; P P Francis; N A D'Souza; N Bhaskaranand
Journal:  Indian J Pediatr       Date:  1994 Jul-Aug       Impact factor: 1.967

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.